Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Centre, Prospective, Single Arm Open Label Series of a Transcatheter Tricuspid Valved Stent Graft System for the Reduction of Tricuspid Regurgitation and Improved Patient Reported Outcomes in Patients With Carcinoid Heart Disease

NCT05064514 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT05064514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Centre, Prospective, Single Arm Open Label Series of a Transcatheter Tricuspid Valved Stent Graft System for the Reduction of Tricuspid Regurgitation and Improved Patient Reported Outcomes in Patients With Carcinoid Heart Disease
Lead sponsor
Queen Mary University of London
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 6, 2022
Completion date
May 21, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid heart disease, carcinoid syndrome, tricuspid regurgitation, tricuspid valve disease